Fig. 34From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseSuperimpositions of the best-docked poses of coumarin analogues in the AChE binding site [50]Back to article page